تشرفت اليوم بتعييني من قبل الجمعية الأوروبية للأورام عضواً ممثلاً لدولة الإمارات العربية المتحدة، وذلك خلال انعقاد المؤتمر الدولي للأورام السنوي للجمعية في العاصمة الإسبانية مدريد.
أتطلع من خلال هذه العضوية إلى تعزيز التعاون الدولي، وتوسيع الشراكات العلمية والبحثية، والمساهمة في تطوير التعليم الطبي والبحث العلمي والارتقاء برعاية مرضى السرطان في دولة الإمارات والمنطقة، بالتعاون مع نخبة من الخبراء والمتخصصين من مختلف أنحاء العالم، من خلال الجمعية الأوروبية للأورام، التي تُعد من أكبر وأبرز الجمعيات العلمية والطبية المتخصصة في مجال الأورام والسرطان عالمياً.
أتقدم بجزيل الشكر والتقدير إلى مجلس إدارة الجمعية الأوروبية للأورام على ثقتهم الكريمة، سائلاً الله تعالى التوفيق والسداد في خدمة وطننا وقيادتنا وأهلنا، والمساهمة في تعزيز مكانة دولة الإمارات في المحافل الطبية والعلمية الدولية.
الموقع الرسمي للجمعية الأوروبية للأورام:
https://t.co/kUUAe5hZYU
“I’ll carry your courage and light with me in this marathon of life.”
Aparna Parikh (@aparna1024) shares a heartfelt tribute to Rachna Shroff, remembering her friendship, courage, and the light she brought to those around her. After running the Chicago Marathon in her memory, Aparna reflects on the grief and gratitude of saying goodbye to a dear friend.
Read her tribute below.
https://t.co/FvzQtIELgz
It was my great pleasure to mentor @rachnatshroff in developing the ph3 S1815 study for #cholangioca (1st group phase 3 for this). We spoke recently & she was eagerly continuing her @UAZCancer role. Such a great loss for us all. With our deepest condolences @RutgersCancer
We are saddened by the passing of Rachna T. Shroff, MD, MS, a renowned physician-scientist who treated people with pancreatic cancer and advanced treatment options for patients facing pancreatic and hepatobiliary cancers. Dr. Shroff passed away following a battle with an aggressive cancer. She was 47.
Through her groundbreaking research and leadership in clinical trials, Dr. Shroff helped move the field forward and expand possibilities for patients. She also collaborated with PanCAN on research related to our Know Your Tumor® precision medicine service, contributing to a deeper understanding of pancreatic cancer.
We extend our heartfelt condolences to her loved ones, colleagues and the many patients whose lives she touched. 💜
Read more from the @UAZMedTucson at 🔗 https://t.co/thVsVaZL4W.
I lit 2 candles in loving and respectful memory of Dr. Rachna Schroff in Notre Dame in Paris and in Strasbourg France. Rest in peace you will always be remembered by your colleagues.
Now living with cancer of unknown primary, Rachna Shroff decided there was something concrete she could do: create a permanent source of funding for the next generation of researchers working in the field.
https://t.co/sBI4bOHcKR
GI oncology is a small world, and we were so fortunate to have you in it, Rachna. Your legacy lives on through the mentees you nurtured, the colleagues you inspired, and the lives you touched and saved. Your impact will be felt for generations. You will be deeply missed ❤️@ASCO
It has been a difficult week processing it all.
Rachna truly reflected the best of us & her
legacy will live on in the patients she cared for,
the trainees she mentored, the colleagues she
brought together & everyone she inspired
She always did what all stars do best…Shine
@ASCO So saddened by this news - Dr. Shroff was a champion of cancer research, education, mentorship and women in science. Deepest condolences to her loved ones, may she rest in peace.
We join the oncology community in mourning the passing of Dr. Rachna T. Shroff, a renowned GI cancers expert and a dedicated ASCO volunteer. We are humbled by her dedication and strive to honor her legacy of commitment and altruism.
Read more: https://t.co/yNlVhoASQi
Heartbroken by the passing of Dr. Rachna Shroff, an extraordinary GI oncologist, leader, and inspiration. I’ll cherish this moment with Rachna and colleagues at #ESMOGI24. Her legacy lives on in the science we advance, the patients we serve, and the next generation we inspire. 💔
I lit 2 candles in loving and respectful memory of Dr. Rachna Schroff in Notre Dame in Paris and in Strasbourg France. Rest in peace you will always be remembered by your colleagues.
Mattehorn study showed EFS improvement and strong OS trend with FLOT+duravalumab. Great news to establish the global standard for fit patients with locally advanced gastric/GEJ cancer. Looking forward to the detail.@OncoAlert@oncodaily
https://t.co/2k7AXt6wIG
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY- Gastric04 Phase 3 Trial
👉ENHERTU more effective than Pacli/Ram
https://t.co/TOduG8XVv3
@myESMO
Very grateful that those oncologists who inspire me to #endcancer also happen to be incredible humans! Thanks to all for coming out in SF to celebrate life and love! ❤️🌈 #GI25